I did just wrap up watching this.
At 2 points Cortexa was brought up
@4:10 Will Avery mentions that during Q1 they didn't ship product to patents under the SAP or to clinical trials and revenue was limited to the Cortexa license fees.
@18:44 A question point blank around any upcoming news with Cortexa Nick Kadysh shuts the question down quick.
Side note, they spend a decent portion of the Webinar talking about finding non dilutive funding to progress their own clinical trials goals.
Just a hypothesis for the moment.
I did just wrap up watching this.At 2 points Cortexa was brought...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.69M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 63702 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 6000 | 1 |
View Market Depth
| Last trade - 09.59am 01/08/2025 (20 minute delay) ? |
| VIT (ASX) Chart |
Day chart unavailable